Ergoresearch Ltd
TSX VENTURE : ERG

Ergoresearch Ltd

July 19, 2012 14:34 ET

Ernst & Young Nominates Egoresearch's Sylvain Boucher as Finalist for Entrepreneur of the Year 2012

LAVAL, QUEBEC--(Marketwire - July 19, 2012) - Ergoresearch (TSX VENTURE:ERG) is proud to announce the nomination of Ergoresearch President and CEO, Sylvain Boucher, as this year's Quebec finalist for the Ernst & Young Entrepreneur Of The Year® Award.

The Canadian program rewards the country's most impressive entrepreneurs from all areas of business. It shines the spotlight on game-changing individuals who continue to drive sustainable growth and job creation across the country. Award finalists are chosen based on their vision, leadership, entrepreneurship and the prosperity of their business.

In each of the nominee categories, Québec award winners will be announced at a banquet on 25 October, while the overall winner will represent the province at the national gala held in Toronto, on 16 January 2013.

About Ergoresearch

Since 2005, Ergoresearch has developed Quebec's leading network of orthotics clinics, with over 60 corporate and satellite centres under the Clinique du Pied Équilibre and Orthoconcept banners. The leading manufacturer of 'intelligent' foot orthotics and specialty orthotics, it is a trend-setter in creating durable medical equipment and software for the orthopedics market. Ergoresearch was the first to develop and market an autocorrecting podo-barometric pad that relies on two distinct software programs to ensure the quality and performance of the orthotics that it produces.

The company is involved in a number of research projects with institutions such as Université Laval, and Collège Mérici's Centre de solutions technologiques en orthèses et prothèses (CSTOP), in Quebec City. Ergoresearch Ltd is listed on the Toronto Stock Exchange (TSX-V) under the TSX-V Symbol: ERG.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Isabelle Vallee
    Director - Communications and Public Relations
    Ergoresearch Ltd
    450-973-6700, x 233
    Cell: 514-377-0485
    ivallee@ergoresearch.com